Efficacy and safety of three different aflibercept regimens in subjects with DME

Update Il y a 4 ans
Reference: EUCTR2014-004938-25

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to evaluate the efficacy of long-term treatment with 2 mg aflibercept via different intravitreal (IVT) treatment regimens to subjects with DME pre-treated for at least one year.


Inclusion criteria

  • Diabetic Macular Edema (DME)